Article
Is small cell lung cancer the perfect target for anti-telomerase treatment?
1 Aug 1999
Abstract excerpt
Small cell lung cancer (SCLC) is common in men and women, has a very poor prognosis, and is therefore a major cause of premature mortality. As such, any prospects for improved therapy are of great significance. The promise of telomerase as a therapeutic target is now close to realization with extremely encouraging preclinical studies aimed at the RNA component (hTR) of telomerase. The rational integration of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
